Sakiko Nakamori

Tokyo Metropolitan Komagome Hospital

Papers

2

Total Citations

5

H-Index

2

About

Dr. Sakiko Nakamori is a surgical oncologist whose research focuses on improving outcomes in colorectal cancer surgery and chemotherapy. Her work centers on two key areas: reducing postoperative complications through minimally invasive techniques and understanding rare chemotherapy-related hepatic toxicities. Dr. Nakamori’s most impactful contribution is a 2023 study documenting a rare case of localized peliosis hepatis—a dangerous liver condition mimicking metastasis—during oxaliplatin-based adjuvant chemotherapy. This work, with 3 citations, provides critical guidance for differentiating chemotherapy-induced liver injury from recurrent disease, directly impacting clinical decision-making. In 2024, she published a comparative study demonstrating that specimen extraction via a Pfannenstiel incision during laparoscopic or robotic colectomy significantly reduces incisional hernia rates compared to traditional midline incisions. This practical finding, already cited twice, offers surgeons an evidence-based technique to improve patient recovery. Dr. Nakamori’s research bridges surgical innovation and oncological safety, providing actionable insights for colorectal cancer management. Her work is particularly valuable for surgeons navigating the balance between aggressive chemotherapy and surgical precision.

Research Focus

Key Achievements

2
H-Index
2
Papers
5
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Tokyo Metropolitan Komagome Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago